Valuation : Pharmena S.A.

Market Cap 36.2M 9.75M 8.39M 7.9M 7.2M 13.47M 928M 13.53M 93.66M 473M 36.62M 35.83M 1.5B P/E 2024
-33.8x
P/E 2025 -10.4x
Enterprise Value 36.21M 9.76M 8.39M 7.9M 7.2M 13.48M 928M 13.53M 93.68M 473M 36.63M 35.84M 1.5B EV / Sales 2024
154x
EV / Sales 2025 18.4x
Free-Float
29.7%
Yield 2024 *
-
Yield 2025 -
1 day+3.08%
1 week+2.45%
Current month+8.06%
1 month+9.12%
3 months+1.82%
6 months-3.18%
Current year+28.85%
1 week 3.09
Extreme 3.09
3.4
1 month 3.02
Extreme 3.02
3.48
Current year 2.56
Extreme 2.56
4.32
1 year 2.5
Extreme 2.5
4.32
3 years 2.5
Extreme 2.5
9.18
5 years 2.5
Extreme 2.5
10.96
10 years 2.5
Extreme 2.5
33.48
Manager TitleAgeSince
Chief Executive Officer - 12/11/2002
Chief Tech/Sci/R&D Officer - 01/04/2008
Director TitleAgeSince
Director/Board Member 62 -
Director/Board Member 63 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.08%+2.45%-8.97%-41.43% 9.76M
-1.67%-0.86%-3.70%-6.25% 240B
-4.46%-6.36%+6.91% - 46.9B
-2.25%-14.80%+65.25% - 10.52B
+0.03%-7.43%+38.10%-40.53% 8.68B
-1.21%-5.47%+16.02%+6.30% 6.44B
-3.56%-6.30%-27.54%-25.73% 6.16B
-1.66%-4.59%-4.18%-15.08% 3.62B
-2.68%-3.70%-27.93%-44.07% 3.62B
+0.57%+0.57%-2.42%-32.62% 2.86B
Average -1.36%-2.89%+5.15%-24.93% 32.92B
Weighted average by Cap. -2.04%+0.70%+0.80%-8.39%

Financials

2024 2025
Net sales 268K 72.21K 62.14K 58.51K 53.31K 99.74K 6.87M 100K 693K 3.5M 271K 265K 11.09M 1.58M 425K 366K 344K 314K 587K 40.43M 589K 4.08M 20.6M 1.6M 1.56M 65.26M
Net income -1.26M -340K -293K -276K -251K -470K -32.36M -472K -3.27M -16.48M -1.28M -1.25M -52.22M -2.77M -746K -642K -605K -551K -1.03M -70.99M -1.03M -7.16M -36.17M -2.8M -2.74M -115M
Net Debt -1.5M -404K -348K -328K -299K -559K -38.48M -561K -3.88M -19.61M -1.52M -1.49M -62.11M 9K 2.42K 2.09K 1.96K 1.79K 3.35K 231K 3.36K 23.29K 118K 9.11K 8.91K 372K
Logo Pharmena S.A.
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Employees
7
Date Price Change Volume
09/09/26 PLN 3.350 +3.08% 2,084
08/09/26 PLN 3.250 +0.93% 2,045
07/09/26 PLN 3.220 -1.23% 2,648
04/09/26 PLN 3.260 0.00% 2,172
03/09/26 PLN 3.260 -0.31% 2,289
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!